Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumera I Ilyas

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Journal of Hepatology|February 7, 2018
Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinomaAyano Kabashima, Petra Hirsova, Steven F Bronk, et al.
Molecular Cancer Research : MCR|July 11, 2020
The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in CholangiocarcinomaEeeLN H Buckarma, Nathan W Werneburg, Caitlin B Conboy, et al.
Hepatology Communications|January 6, 2026
Low serum pseudocholinesterase levels are associated with mortality in patients with hepatocellular carcinomaKarina Sato-Espinoza, Marie-Lise Chrysostome, Robert A Vierkant, et al.
The British Journal of Surgery|July 18, 2022
Hepatobiliary and pancreatic resection for cholangiocarcinoma in patients with primary sclerosing cholangitisRon Pery, Rory L Smoot, Cornelius A Thiels, et al.
Nature Reviews. Disease Primers|September 10, 2021
CholangiocarcinomaPaul J Brindley, Melinda Bachini, Sumera I Ilyas, et al.
Oncotarget|February 22, 2018
YAP-associated chromosomal instability and cholangiocarcinoma in miceSumera I Ilyas, Samantha R Fischbach, Steven F Bronk, et al.
Cancer Research|July 22, 2010
Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesisSumera I Ilyas, Cathrine J Demars, Andrea Comba, et al.
The Journal of Biological Chemistry|February 16, 2010
Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesisNavtej S Buttar, Cathrine J DeMars, Gwen Lomberk, et al.
JHEP Reports : Innovation in Hepatology|December 3, 2025
Failure-to-rescue as a determinant of overall survival following resection for perihilar cholangiocarcinomaYawen Dong, Zhihao Li, Vanja Podrascanin, et al.
Hepatology (Baltimore, Md.)|January 13, 2015
IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanismDaisaku Yamada, Sumera I Ilyas, Nataliya Razumilava, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Journal of Hepatology|February 7, 2018
Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinomaAyano Kabashima, Petra Hirsova, Steven F Bronk, et al.
Molecular Cancer Research : MCR|July 11, 2020
The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in CholangiocarcinomaEeeLN H Buckarma, Nathan W Werneburg, Caitlin B Conboy, et al.
Hepatology Communications|January 6, 2026
Low serum pseudocholinesterase levels are associated with mortality in patients with hepatocellular carcinomaKarina Sato-Espinoza, Marie-Lise Chrysostome, Robert A Vierkant, et al.
The British Journal of Surgery|July 18, 2022
Hepatobiliary and pancreatic resection for cholangiocarcinoma in patients with primary sclerosing cholangitisRon Pery, Rory L Smoot, Cornelius A Thiels, et al.
Nature Reviews. Disease Primers|September 10, 2021
CholangiocarcinomaPaul J Brindley, Melinda Bachini, Sumera I Ilyas, et al.
Oncotarget|February 22, 2018
YAP-associated chromosomal instability and cholangiocarcinoma in miceSumera I Ilyas, Samantha R Fischbach, Steven F Bronk, et al.
Cancer Research|July 22, 2010
Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesisSumera I Ilyas, Cathrine J Demars, Andrea Comba, et al.
The Journal of Biological Chemistry|February 16, 2010
Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesisNavtej S Buttar, Cathrine J DeMars, Gwen Lomberk, et al.
JHEP Reports : Innovation in Hepatology|December 3, 2025
Failure-to-rescue as a determinant of overall survival following resection for perihilar cholangiocarcinomaYawen Dong, Zhihao Li, Vanja Podrascanin, et al.
Hepatology (Baltimore, Md.)|January 13, 2015
IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanismDaisaku Yamada, Sumera I Ilyas, Nataliya Razumilava, et al.
Pageof 9